Login
Toggle navigation
Videos
Categories
Trending
Business Growth Plans: Diversifying Product Lines and Strengthening Technology Integration|Dhiraj Patel,Managing Director,Vikram Thermo (India) Ltd.
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Dhiraj Patel,Chaiman and Managing Director
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Addressing High RMS Errors and Inversion Artifacts in Electrical Resistivity Imaging
00:10:00
Colonial Coal CEO Dave Austin: “With Over 20 Buyers at the Table, We’re Positioned for a Strategic Sale of One of the World’s Premier Coking Coal Assets”
00:10:00
Calfrac Well Services - 20th Anniversary message from Ron Mathison | Pat Powell, CEO, Calfrac Well Services LtdCFW:TOR
00:10:00
Exploring Innovative VR Training for Mining at Northern Ontario Showcase
00:10:00
Owl Ventures is the largest venture capital firm in the world|Malvika Bhagwat,Partner and Head of Outcomes,Owl Ventures
00:10:00
Tinka Resources CEO Graham Carman Highlights Exciting Times Amid Zinc Surge and Exploration Milestones
00:10:00
The market that is important, But Strategy is not timing|Professor Jon Rushman,INVESTMENT COMMITTEE,Walden Capital Partners, L.P.
00:10:00
Nordic Real Estate Acquisition Discussed by CEO | Erik Selin, CEO, Fastighets AB Balder.
00:10:00
focus on digital health and enterprise with a little bit of automation and writing initial checks typically more on their investment thesis|Amit Garg,Managing Partner,Tau Ventures
00:10:00
Momentus Stock Soars After Key National Security Agreement Termination
00:10:00
Financial Performance and Operational Excellence of Silvercorp Metals
00:10:00
Boosted by strong performance, Baader Bank AG's stock is discussed alongside 7C Solarparken CEO Steven De Proost's insights on goals, growth, and directors' dealings in SdK Talk.